views

A little under three years ago, I first wrote about Smith & Nephew (SN.), which “designs and makes technology that takes the limits off living, and we help healthcare professionals to achieve the same goal”. All good stuff, but - as shown by the 70% fall in share price since October 2019 - life for this sort of business has got more tricky.  And the then-CEO did not listen to my advice: that he needed “to focus on performance and not pay”. Unsurprisingly, he has left, chasing more money… So, what about the new(ish) CEO and prospects for Smith & Nephew shares, now at a five-year low?

views

Hello Share Finders. There’s evidence the share world hasn't yet woken to the prospect of a better future for big medical companies. All that coverage on tv is just one example of how interest in the field is gaining. I imagine many kids now want to be doctors or nurses. And the majority of folks in Britain say they’re happier to pay higher taxes to support the NHS. A company that will do well out of extra dosh being pumped into health services around the world is Smith and Nephew (SN.).

NEWSFLOW

views

Hello Share Searchers. There’s a strong case for companies connected to hospitals these days. With or without Covid, medics still need the latest equipment. Step forward Smith & Nephew (SN.), an £11 billion company that does artificial joints, sports recovery and injury management. Some of this is assisted with ground-breaking robots.

views

Hello, Share Takers. With the current Covid situation, it seems a good idea to look at medical firms. However, Smith and Nephew (SN.) is an industry giant that has not benefitted from the plague. This is because it makes hip and knee replacements and zillions of such operations have been cancelled. So the share price has suffered. However, the management mounted a positive presentation the other day. And now the City's started to take notice.

NEWSFLOW

NEWSFLOW

NEWSFLOW

NEWSFLOW

NEWSFLOW